{"product_id":"biolegend-100204","title":"Biolegend, 100204, FITC anti-mouse CD3 Antibody, 500μg","description":"\u003cp\u003eCD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α\/β or γ\/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide\/MHC antigen complex\u003cbr\u003e\n500μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: γδTCR-positive T-T hybridoma D1\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.\u003cbr\u003e\nConcentration: 0.5 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)\u003cbr\u003e\nApplication Notes: Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed\u003cbr\u003e\nProduct Citations: Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed Zaman R, et al. 2021. Immunity. :. PubMed Yu X, et al. 2020. Nat Commun. 11:1110. PubMed Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed Chen H, et al. 2023. Nat Commun. 14:941. PubMed Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed Guo D, et al. 2023. Cell Biosci. 13:51. PubMed Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed Ito M, et al. 2023. Sci Rep. 13:5939. PubMed Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed Zuo B, et al. 2023. Clin Transl Oncol. . PubMed Bhaskar A, et al. 2023. iScience. 26:106644. PubMed Wang K, et al. 2023. Nat Commun. 14:2950. PubMed Wang D, et al. 2023. Nat Commun. 14:2943. PubMed Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed Feng X, et al. 2023. Nat Commun. 14:3208. PubMed Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed Lan Y, et al. 2023. iScience. 26:106817. PubMed Yang QC, et al. 2023. iScience. 26:106916. PubMed Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed Harel M, et al. 2020. J Immunol. 205:1167. PubMed Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed Pei J, et al. 2022. J Virol. 96:e0194221. PubMed Li X, et al. 2022. J Clin Invest. 132: . PubMed Meng J, et al. 2022. Cell Rep. 38:110492. PubMed Corral D, et al. 2022. Cell Rep. 39:110715. PubMed Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed Wu J, et al. 2023. Bioact Mater. 20:259. PubMed Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed Xie DH, et al. 2022. Med Phys. 49:6728. PubMed Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed Gao Y, et al. 2022. Cell Res. 32:1086. PubMed Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed Kim HI, et al. 2022. Molecules. 27: . PubMed Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed Yu J, et al. 2022. Nat Commun. 13:7903. PubMed Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed Ding L, et al. 2023. J Clin Invest. 133: . PubMed Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed Liu H, et al. 2023. Cell Death Differ. :. PubMed Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed Zhang W, et al. 2022. Dev Cell. 57:329. PubMed Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed Miller CM, et al. 2020. J Virol. 94:00:00. PubMed Boyd DF, et al. 2020. Nature. 587:466. PubMed Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed Lin W, et al. 2020. Theranostics. 10:4871. PubMed Gawish R, et al. 2022. Elife. 11:. PubMed Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed Li Q, et al. 2022. Cell Rep. 40:111308. PubMed Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed Jiang Q, et al. 2022. Theranostics. 12:59. PubMed Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed Ford K, et al. 2020. Cancer Res. 80:1846. PubMed Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed Tang L, et al. 2021. Oncol Lett. 22:605. PubMed Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed Song C, et al. 2019. Nat Commun. 10:3745. PubMed Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed Turner JA, et al. 2020. Immunity. 53:1202. PubMed Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed Mei S, et al. 2022. Front Immunol. 13:911164. PubMed Lu H, et al. 2021. Autophagy. 17:2511. PubMed Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed Diao L, et al. 2022. iScience. 25:105511. PubMed Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed Ren J, et al. 2021. Theranostics. 11:304. PubMed Tan X, et al. 2021. Front Oncol. 11:768222. PubMed Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed Pham THM, et al. 2020. Cell Host \u0026amp; Microbe. 27(1):54-67.e5.. PubMed Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed White C, et al. 2014. J Immunol. 193:5933. PubMed Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed Ning X, et al. 2019. Mol Cell. 74:19. PubMed Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed Deng P, et al. 2022. Cells. 11:. PubMed Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed Zhan Y, et al. 2021. JCI Insight. 6:. PubMed Lee M, et al. 2014. PLoS One. 9:112666. PubMed Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed Solanki A, et al. 2018. Development. 145. PubMed Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed Yang S, et al. 2019. Nat Commun. 10:2782. PubMed Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed Shi R, et al. 2022. Theranostics. 12:875. PubMed Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed Markey K, et al. 2014. J Immunol. 192:5426. PubMed Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed Li W, et al. 2019. Nat Commun. 10:3349. PubMed Xu X, et al. 2018. Cell. 175:1336. PubMed Reismann D, et al. 2017. Nat Commun.. 10.1038\/s41467-017-01538-9. PubMed Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed Tang X, et al. 2022. Cell Rep. 41:111673. PubMed Wei W, et al. 2022. mSystems. 7:e0046922. PubMed Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed Yang J, et al. 2022. Microbiome. 10:149. PubMed Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed Koren E, et al. 2022. Nat Commun. 13:4628. PubMed Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed Chen X, et al. 2021. Cell Rep. 37:109991. PubMed Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed Reinfeld BI, et al. 2021. Nature. 593:282. PubMed Du J, et al. 2012. Stem Cells. 30:1447. PubMed Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed Kruta M, et al. 2021. Cell Stem Cell. :. PubMed Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed França TT, et al. 2021. JCI Insight. 6:. PubMed Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed Sun C, et al. 2022. J Adv Res. 35:71. PubMed Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed Yu X, et al. 2019. Nat Commun. 10:574. PubMed Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed Ma W, et al. 2017. Cell Death \u0026amp; Disease. 10.1038\/cddis.2017.47. PubMed Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed Frost JN, et al. 2021. Med (N Y). 2:164. PubMed Port JR, et al. 2020. J Virol. 94:. PubMed Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed Nowlan B, et al. 2019. Haematologica. 105:71. PubMed Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed Yu H, et al. 2021. Front Oncol. 11:736882. PubMed Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Wu L, et al. 2020. Cell Rep. 33:108327. PubMed Zan H, et al. 2017. Nat Commun. 8:14244. PubMed Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed Scally S, et al. 2017. Nat Commun. . 10.1038\/s41467-017-01924-3. PubMed Yi H, et al. 2021. Front Immunol. 12:719189. PubMed Qi J, et al. 2021. Nat Commun. 12:4755. PubMed Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed Li X, et al. 2021. Cell Death Dis. 12:314. PubMed Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed Zhang J, et al. 2022. Biomater Res. 26:44. PubMed Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed Jia H, et al. 2018. Int J Oncol. 53:949. PubMed Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed Le QV, et al. 2022. Bioact Mater. 15:160. PubMed Aulova KS, et al. 2022. Molecules. 27:. PubMed Yang N, et al. 2022. Nat Commun. 13:2336. PubMed Guo X, et al. 2020. J Cell Mol Med. . PubMed Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed Li K, et al. 2020. Nat Commun. 0.795138889. PubMed Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed Tao Z, et al. 2022. Cells. 11:. PubMed Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed Wang F, et al. 2021. Neoplasia. 23:281. PubMed Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed Zheng Y, et al. 2022. Transl Res. :. PubMed Gawish R, et al. 2022. Elife. 11:. PubMed Li J, et al. 2022. Nat Commun. 13:1481. PubMed Li J, et al. 2021. eLife. 10:00. PubMed Trivedi S, et al. 2020. Elife. 9:00. PubMed Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed Fan X, et al. 2014. PLoS One. 9:107638. PubMed Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed Cao Y, et al. 2022. Small. 18:e2203466. PubMed Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed Erens C, et al. 2022. Biomedicines. 10:. PubMed Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed Gu Z, et al. 2021. Nat Genet. 53:672. PubMed Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed\u003cbr\u003e\nRRID: AB_312660 (BioLegend Cat. No. 100203) AB_312661 (BioLegend Cat. No. 100204)\u003cbr\u003e\nStructure: Ig superfamily, CD3\/TCR, 20 kD\u003cbr\u003e\nDistribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells\u003cbr\u003e\nFunction: Antigen recognition, TCR signal transduction, T cell activation\u003cbr\u003e\nLigand\/Receptor: Peptide antigen\/MHC-complex\u003cbr\u003e\nAntigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.\u003cbr\u003e\nGene ID: 12502\u003cbr\u003e\nUniProt: View information about CD3 on UniProt.org\u003cbr\u003e\nClone: 17A2\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: T cell antigen receptor complex, T3\u003cbr\u003e\nIsotype: Rat IgG2b, κ\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46860821725353,"sku":"100204","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-100204","provider":"Iright","version":"1.0","type":"link"}